Literature DB >> 17465807

Regional and global protective effects of tissue kallikrein gene delivery to the peri-infarct myocardium.

Frank Spillmann1, Gallia Graiani, Sophie Van Linthout, Marco Meloni, Ilaria Campesi, Costanza Lagrasta, Dirk Westermann, Carsten Tschöpe, Federico Quaini, Costanza Emanueli, Paolo Madeddu.   

Abstract

BACKGROUND: The kallikrein-kinin system participates in the maintenance of the cardiovascular phenotype. We previously demonstrated that human tissue kallikrein gene (hTK) transfer promotes the healing of ischemic limbs. The present investigation aimed to test the original hypothesis that hTK delivery to the peri-infarct myocardium would prevent post-ischemic heart failure. METHODS AND
RESULTS: Myocardial infarction (MI) was induced in anesthetized mice by permanently occluding the left coronary descendant. hTK was delivered to the peri-infarct myocardium via an adenoviral vector (Ad.hTK). Controls received Ad.Null or saline. Survival rate was similar among groups. Ad.hTK increased the number of circulating endothelial progenitor cells and promoted the growth of capillaries and arterioles in the peri-infarct myocardium. In addition, Ad.hTK increased the abundance of cardiac progenitor cells (CPCs) in the peri-infarct and suppressed the apoptotic death of peri-infarct cardiomyocytes in vivo and ex vivo. As a consequence of these beneficial effects, at 5 weeks from MI, hTK-transduced hearts were protected from post-MI ventricular dilatation and showed better systolic and diastolic functions.
CONCLUSIONS: Ad.hTK benefits the neovascularization and viability of peri-infarct myocardium and increases CPC abundance, thereby decreasing ventricular dysfunction. Our study significantly adds to the knowledge of the protective effects of TK gene transfer on ischemic diseases and opens new avenues for the treatment of post-MI cardiac failure.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17465807     DOI: 10.2217/17460751.1.2.235

Source DB:  PubMed          Journal:  Regen Med        ISSN: 1746-0751            Impact factor:   3.806


  11 in total

Review 1.  Kallikrein-kinin in stem cell therapy.

Authors:  Julie Chao; Grant Bledsoe; Lee Chao
Journal:  World J Stem Cells       Date:  2014-09-26       Impact factor: 5.326

2.  Tissue kallikrein promotes cardiac neovascularization by enhancing endothelial progenitor cell functional capacity.

Authors:  Yuyu Yao; Zulong Sheng; Yefei Li; Fengdi Yan; Cong Fu; Yongjun Li; Genshan Ma; Naifeng Liu; Julie Chao; Lee Chao
Journal:  Hum Gene Ther       Date:  2012-04-30       Impact factor: 5.695

3.  Benfotiamine improves functional recovery of the infarcted heart via activation of pro-survival G6PD/Akt signaling pathway and modulation of neurohormonal response.

Authors:  Rajesh Katare; Andrea Caporali; Costanza Emanueli; Paolo Madeddu
Journal:  J Mol Cell Cardiol       Date:  2010-06-08       Impact factor: 5.000

4.  Identification of the prosurvival activity of nerve growth factor on cardiac myocytes.

Authors:  A Caporali; G B Sala-Newby; M Meloni; G Graiani; E Pani; B Cristofaro; A C Newby; P Madeddu; C Emanueli
Journal:  Cell Death Differ       Date:  2007-11-09       Impact factor: 15.828

5.  Involvement of phosphoinositide 3-kinase gamma in angiogenesis and healing of experimental myocardial infarction in mice.

Authors:  Mauro Siragusa; Rajesh Katare; Marco Meloni; Federico Damilano; Emilio Hirsch; Costanza Emanueli; Paolo Madeddu
Journal:  Circ Res       Date:  2010-01-07       Impact factor: 17.367

6.  Effects of a novel bradykinin B1 receptor antagonist and angiotensin II receptor blockade on experimental myocardial infarction in rats.

Authors:  Dongmei Wu; Xinchun Lin; Christian Bernloehr; Tobias Hildebrandt; Henri Doods
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

7.  Human Tissue Kallikrein Activity in Angiographically Documented Chronic Stable Coronary Artery Disease.

Authors:  Estêvão Lanna Figueiredo; Carolina Antunes Magalhães; Karlyse Claudino Belli; Ari Mandil; José Carlos Faria Garcia; Rosanã Aparecida Araújo; Amintas Fabiano de Souza Figueiredo; Lucia Campos Pellanda
Journal:  Arq Bras Cardiol       Date:  2015-09-04       Impact factor: 2.000

8.  CX3CR1 knockout aggravates Coxsackievirus B3-induced myocarditis.

Authors:  Irene Müller; Kathleen Pappritz; Konstantinos Savvatis; Kerstin Puhl; Fengquan Dong; Muhammad El-Shafeey; Nazha Hamdani; Isabell Hamann; Michel Noutsias; Carmen Infante-Duarte; Wolfgang A Linke; Sophie Van Linthout; Carsten Tschöpe
Journal:  PLoS One       Date:  2017-08-11       Impact factor: 3.240

Review 9.  Genetically‑modified stem cells in treatment of human diseases: Tissue kallikrein (KLK1)‑based targeted therapy (Review).

Authors:  Marina Devetzi; Maria Goulielmaki; Nicolas Khoury; Demetrios A Spandidos; Georgia Sotiropoulou; Ioannis Christodoulou; Vassilis Zoumpourlis
Journal:  Int J Mol Med       Date:  2018-01-03       Impact factor: 4.101

10.  Role of kinin B2 receptor signaling in the recruitment of circulating progenitor cells with neovascularization potential.

Authors:  Nicolle Kränkel; Rajesh G Katare; Mauro Siragusa; Luciola S Barcelos; Paola Campagnolo; Giuseppe Mangialardi; Orazio Fortunato; Gaia Spinetti; Nguyen Tran; Kai Zacharowski; Wojciech Wojakowski; Iwona Mroz; Andrew Herman; Jocelyn E Manning Fox; Patrick E MacDonald; Joost P Schanstra; Jean Loup Bascands; Raimondo Ascione; Gianni Angelini; Costanza Emanueli; Paolo Madeddu
Journal:  Circ Res       Date:  2008-10-16       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.